OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
600367$29.7856

Guizhou Redstar Developing Co Ltd

Commodity ChemicalsVerified

Guizhou Redstar has a market capitalization of CNY 10.16 billion and a price-to-earnings ratio of 109.44, indicating a high valuation relative to its earnings. The company's price-to-book ratio of 4.13 suggests that the market is valuing its equity at a premium to its book value. The liquidity position is characterized by a current ratio of 3.72, which is significantly above the industry median, indicating strong short-term liquidity. However, the company has a negative net cash position after subtracting total debt, signaling potential liquidity risk. The company's profitability is modest, with a return on equity (ROE) of 3.78% and a return on assets (ROA) of 2.82%, both below the industry median for commodity chemicals. The gross profit margin is 23.52%, and the operating margin is 6.84%, which are in line with the industry but do not suggest a competitive advantage in cost control or pricing power. The net income of CNY 92.83 million is relatively low compared to the company's revenue of CNY 2.14 billion, indicating that the business is not highly profitable. Guizhou Redstar's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of segment and geographic diversification increases the company's exposure to sector-specific and regional economic risks. The company's capital structure is relatively conservative, with a debt-to-equity ratio of 0.03, indicating that it is primarily financed through equity rather than debt. The company's growth trajectory is uncertain, with no specific revenue growth projections provided in the available data. The capital expenditure of CNY -223.25 million suggests that the company is not investing heavily in new projects or capacity expansion, which could limit its long-term growth potential. The free cash flow of CNY 31.99 million is positive but relatively small, which may constrain the company's ability to fund dividends, share buybacks, or new investments. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a key liquidity flag, suggesting that it may need to raise additional capital in the near term to maintain its operations. The dilution risk is low, as the number of shares outstanding has not changed between basic and diluted shares, indicating no imminent threat from share issuance or convertible instruments. Recent financial filings and transcripts do not provide specific details on strategic initiatives or operational changes. The company's financial performance appears to be stable but not growing, with no significant events reported in the available data that would suggest a material change in its business model or market position.

30-day price · 600367+12.21 (+58.1%)
Low$20.18High$33.22Close$33.22As of28 May, 00:00 UTC
Profile
CompanyGuizhou Redstar Developing Co Ltd
Ticker600367.SS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Guizhou Redstar Developing Co Ltd is a Chinese chemicals company that produces and sells commodity chemicals, primarily generating revenue through the sale of chemical products to industrial and manufacturing customers.

Classification. Guizhou Redstar is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a high confidence level of 0.92 based on verified market data.

Guizhou Redstar has a market capitalization of CNY 10.16 billion and a price-to-earnings ratio of 109.44, indicating a high valuation relative to its earnings. The company's price-to-book ratio of 4.13 suggests that the market is valuing its equity at a premium to its book value. The liquidity position is characterized by a current ratio of 3.72, which is significantly above the industry median, indicating strong short-term liquidity. However, the company has a negative net cash position after subtracting total debt, signaling potential liquidity risk. The company's profitability is modest, with a return on equity (ROE) of 3.78% and a return on assets (ROA) of 2.82%, both below the industry median for commodity chemicals. The gross profit margin is 23.52%, and the operating margin is 6.84%, which are in line with the industry but do not suggest a competitive advantage in cost control or pricing power. The net income of CNY 92.83 million is relatively low compared to the company's revenue of CNY 2.14 billion, indicating that the business is not highly profitable. Guizhou Redstar's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of segment and geographic diversification increases the company's exposure to sector-specific and regional economic risks. The company's capital structure is relatively conservative, with a debt-to-equity ratio of 0.03, indicating that it is primarily financed through equity rather than debt. The company's growth trajectory is uncertain, with no specific revenue growth projections provided in the available data. The capital expenditure of CNY -223.25 million suggests that the company is not investing heavily in new projects or capacity expansion, which could limit its long-term growth potential. The free cash flow of CNY 31.99 million is positive but relatively small, which may constrain the company's ability to fund dividends, share buybacks, or new investments. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a key liquidity flag, suggesting that it may need to raise additional capital in the near term to maintain its operations. The dilution risk is low, as the number of shares outstanding has not changed between basic and diluted shares, indicating no imminent threat from share issuance or convertible instruments. Recent financial filings and transcripts do not provide specific details on strategic initiatives or operational changes. The company's financial performance appears to be stable but not growing, with no significant events reported in the available data that would suggest a material change in its business model or market position.
Key takeaways
  • Guizhou Redstar is a commodity chemicals company with a high price-to-earnings ratio and a premium valuation relative to book value.
  • The company's profitability is modest, with ROE and ROA below industry medians, and no clear competitive advantage in cost control or pricing.
  • The business is not diversified across segments or geographies, increasing exposure to sector-specific and regional risks.
  • The company's capital structure is conservative, but its negative net cash position raises liquidity concerns.
  • Growth is limited by low capital expenditure and minimal free cash flow, which may constrain long-term expansion or shareholder returns.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$2.14B
Gross profit$502.2M
Operating income$146.1M
Net income$92.8M
R&D
SG&A
D&A
SBC
Operating cash flow$186.3M
CapEx-$223.3M
Free cash flow$32.0M
Total assets$3.30B
Total liabilities$838.6M
Total equity$2.46B
Cash & equivalents
Long-term debt$76.4M
Valuation
Market price$29.78
Market cap$10.16B
Enterprise value$10.24B
P/E109.4
Reported non-GAAP P/E
EV/Revenue4.8
EV/Op income70.0
EV/OCF54.9
P/B4.1
P/Tangible book4.1
Tangible book$2.46B
Net cash-$76.4M
Current ratio3.7
Debt/Equity0.0
ROA2.8%
ROE3.8%
Cash conversion2.0%
CapEx/Revenue-10.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
Metric600367Activity
Op margin6.8%5.5% medp25 -0.0% · p75 10.8%above median
Net margin4.3%4.1% medp25 0.1% · p75 8.8%above median
Gross margin23.5%20.5% medp25 12.4% · p75 29.7%above median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-10.5%-6.2% medp25 -13.4% · p75 -2.6%below median
Debt / equity3.0%37.1% medp25 10.3% · p75 82.0%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-21 05:56 UTC#bf2a0539
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 00:16 UTCJob: 7d82b9fc